Finanzwire Finanzwire
Basculer en Français
11313 Companies
251397 Keywords
180498 Articles
137244 Press releases
Headlines Articles Press releases Norgine Pharmaceuticals Limited Remove
  1. Home
  2. Companies
  3. Norgine Pharmaceuticals Limited
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 12/17/2025 at 09:10, 10 months 24 days ago

    Norgine Secures Licensing Deal with Vir Biotechnology for Hepatitis Delta Treatment

    Pharmaceuticals Licensing Agreement Norgine Vir Biotechnology Hepatitis Delta
  • PRESS RELEASE

    published on 12/17/2025 at 09:05, 10 months 24 days ago

    Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology

    Norgine enhances hepatology and specialty portfolio by in-licensing Vir Biotechnology's chronic hepatitis delta treatment for Europe, Australia, and New Zealand
    Exclusive Licensing Agreement Specialty Pharmaceuticals Norgine Vir Biotechnology Chronic Hepatitis Delta Treatment
    Logo of Norgine Pharmaceuticals Limited
Accesswire
  • Published on 11/10/2026 at 23:00, 22 minutes ago

    Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary

  • Published on 11/10/2026 at 23:00, 22 minutes ago

    Battery X Metals Announces Appointment of Chief Financial Officer and Corporate Secretary

  • Published on 11/10/2026 at 23:00, 22 minutes ago

    Condor Agrees to Short Extension of Lucero Closing Payment with ELEMENT79 and Provides Huiñac Punta Drill Program Update

  • Published on 11/10/2026 at 22:30, 52 minutes ago

    Amdocs Announces First Quarter Fiscal 2027 Investor Conference Schedule

  • Published on 11/10/2026 at 22:00, 1 hour 22 minutes ago

    Worksport Q3 Net Sales Increase 44.2% Year-Over-Year to a Record $7.2 Million Worksport (NASDAQ: WKSP) Q3 Revenue Rises 44% to Record $7.23 Million as Net Loss Narrows 28%

View all ACCESSWIRE
EQS Group
  • Published on 11/10/2026 at 23:15, 6 minutes ago

    GSMA MWC26 Doha welcomed over 10,000 attendees, as world-first ITU co-location puts MENA at the centre of global connectivity policy and innovation

  • Published on 11/10/2026 at 21:24, 1 hour 57 minutes ago

    EQS-Adhoc: Kapsch TrafficCom AG:

  • Published on 11/10/2026 at 21:18, 2 hours 3 minutes ago

    ARYZTA director steps down

  • Published on 11/10/2026 at 18:54, 4 hours 27 minutes ago

    REPLOID Group AG pursues entry in the US market and secures exclusivity to conduct due diligence for the potential acquisition of Chapul, LLC.

  • Published on 11/10/2026 at 18:45, 4 hours 36 minutes ago

    Special Optics Introduces Purpose-Built Microscope Objectives for Quantum Applications

View all EQS
Les Echos
  • Published on 11/10/2026 at 17:31, 5 hours 50 minutes ago

    CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.

  • Published on 11/10/2026 at 14:00, 9 hours 21 minutes ago

    Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026

  • Published on 11/10/2026 at 11:02, 12 hours 19 minutes ago

    Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026

  • Published on 11/10/2026 at 07:00, 16 hours 22 minutes ago

    bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance

  • Published on 11/09/2026 at 18:30, 1 day 4 hours ago

    Air Liquide has successfully issued a CHF 390 million multi-tranche bond

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy